AbbVie
ABBV
#27
Rank
HK$3.767 T
Marketcap
HK$2,132
Share price
0.12%
Change (1 day)
17.68%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): HK$27.93

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.02. In 2025 the company made an earnings per share (EPS) of HK$18.77 a decrease over its 2024 EPS that were of HK$19.01.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.9348.82%
2025HK$18.77-1.26%
2024HK$19.01-11.86%
2023HK$21.57-58.95%
2022HK$52.542.49%
2021HK$51.26121.58%
2020HK$23.13-44.7%
2019HK$41.8345.84%
2018HK$28.689.72%
2017HK$26.14-9.54%
2016HK$28.9016.28%
2015HK$24.85184.1%
2014HK$8.75-57.15%
2013HK$20.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-78.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.52 736.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.29 354.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$44.57 59.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$20.40-172.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.63 27.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.42 87.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$25.09-10.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$55.33 97.45%๐Ÿ‡บ๐Ÿ‡ธ USA